Womble Bond Dickinson IP Litigation attorneys Daniel Attaway, Mary Bourke and Dana Severance were speakers at the recent IP Forum for Life Sciences. 

Their presentation addressed “Infringement, Knowledge, and Intent—Proving Inducement in the Life Sciences.” Specific topics included:

  • What evidence is sufficient to show intent in the ANDA/BLA context versus when a product is on the market?
  • What impacts will GSK v. Teva have on the future of skinny-labeling?
  • How can the regulatory process affect the chances of proving inducement?

The IP Forum for Life Sciences took place Dec. 4-7 at the Biltmore Hotel Miami in Coral Gables, Fla. The event was presented by Consero.